The recently released South Indian film Kanguva, starring Suriya, has made headlines for its box office performance since hitting theaters on November 14, 2024. Despite initial excitement and a significant budget of ₹300 crore, the film has struggled to meet expectations, leading to a disappointing box office collection.
Kanguva: A Brief Overview
Kanguva is directed by Siva and features a star-studded cast including Disha Patani and Bobby Deol. The film is a fantasy action drama that spans three hours and is said to be based on a story set 15 years ago. Suriya plays a dual role, portraying both a warrior from the past and a modern-day cop. The film’s narrative revolves around themes of protection and valor against invaders.
Box Office Performance
Upon its release, Kanguva experienced a strong opening day, grossing approximately ₹24 crore. However, the momentum quickly waned, with daily earnings plummeting in the following weeks. Here are the key figures from its box office journey:
- Total Earnings: As of November 29, 2024, the film has grossed around ₹69.10 crore across all languages in India.
- Daily Earnings Decline:
- Day 1: ₹24 crore
- Day 2: ₹14.4 crore
- Day 3: ₹14.45 crore
- Day 12: ₹13 lakh
- Day 15: ₹40 lakh
The film’s performance has been particularly weak in the Hindi market, where it has only managed to collect ₹14.42 crore.
Occupancy Rates
Occupancy rates have also reflected the film’s struggles:
- Tamil screenings averaged around 10.41%, with morning shows as low as 8.49%.
- Hindi screenings fared worse, recording an overall occupancy of just 5.11%.
Critical Reception
The critical response to Kanguva has been mixed, with many reviews highlighting Suriya’s commendable performance but criticizing the film’s convoluted storytelling and pacing issues. ETimes rated the film 2.5 out of 5, noting that while Suriya’s dual portrayal was impressive, the overall execution left much to be desired.
Conclusion
In summary, while Kanguva had high expectations due to its hefty budget and star power, it has not performed well at the box office. With ongoing low daily collections and mixed reviews from audiences and critics alike, it faces an uphill battle to recover its investment in the coming weeks.